Post-cesarean Pain Control Via Continuous Infusion of Ropivacain et Diclogenac Into the Wound Versus Intathecal Morphine
Status:
Withdrawn
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The goal is to compare the quality of post-cesarean analgesia, the side effects and the
incidence of residual scar pain obtained with intrathecal morphine (reference treatment) or
with a continuous intra-wound solution including both ropivacain and diclofenac (experimental
treatment).